From the Guidelines
Coumarin cleanses are not recommended due to the lack of scientific evidence supporting their health benefits and potential safety concerns, including liver damage at high doses, as reported in various studies 1, 2, 3, 4, 5, 6. The liver and kidneys already effectively remove waste from the body without needing special cleanses. Some key points to consider:
- Coumarin is a naturally occurring compound found in some plants like cinnamon, but it has no proven detoxifying properties.
- Concentrated coumarin can be harmful, potentially causing liver damage at high doses.
- Some people are also genetically more sensitive to coumarin's effects.
- If you're interested in supporting your body's natural detoxification processes, focus instead on: + Drinking adequate water + Eating a balanced diet rich in fruits and vegetables + Getting regular exercise + Ensuring sufficient sleep These evidence-based approaches support overall health more effectively than unproven cleanse products. If you're experiencing health issues that make a cleanse seem appealing, it's better to consult with a healthcare provider who can address your specific concerns with proven medical approaches, as suggested by recent guidelines 5.
From the FDA Drug Label
The following factors, alone or in combination, may be responsible for DECREASED PT/INR response: ENDOGENOUS FACTORS: edema hypothyroidism hereditary coumarin resistance nephrotic syndrome hyperlipemia EXOGENOUS FACTORS: Potential drug interactions with warfarin sodium tablets are listed below by drug class and by specific drugs Classes of Drugs also: diet high in vitamin K unreliable PT/INR determinations
- Increased and decreased PT/INR responses have been reported † Vitamins† Specific Drugs Reported: alcohol warfarin sodium underdosage phenytoin aminoglutethimide cyclophosphamide pravastatin amobarbital dicloxacillin prednisone atorvastatin ethchlorvynol primidone azathioprine glutethimide propylthiouracil butabarbital griseofulvin raloxifene butalbital haloperidol ranitidine carbamazepine meprobamate rifampin chloral hydrate 6-mercaptopurine secobarbital chlordiazepoxide methimazole spironolactone chlorthalidone moricizine hydrochloride sucralfate cholestyramine nafcillin trazodone clozapine paraldehyde vitamin C (high dose) corticotropin pentobarbital vitamin K cortisone phenobarbital Because a patient may be exposed to a combination of the above factors, the net effect of warfarin sodium tablets on PT/INR response may be unpredictable More frequent PT/INR monitoring is therefore advisable. Medications of unknown interaction with coumarins are best regarded with caution. When these medications are started or stopped, more frequent PT/INR monitoring is advisable. It has been reported that concomitant administration of warfarin and ticlopidine may be associated with cholestatic hepatitis Botanical (Herbal) Medicines Caution should be exercised when botanical medicines (botanicals) are taken concomitantly with warfarin sodium tablets. Few adequate, well-controlled studies exist evaluating the potential for metabolic and/or pharmacologic interactions between botanicals and warfarin sodium tablets Due to a lack of manufacturing standardization with botanical medicinal preparations, the amount of active ingredients may vary. This could further confound the ability to assess potential interactions and effects on anticoagulation. It is good practice to monitor the patient’s response with additional PT/INR determinations when initiating or discontinuing botanicals Specific botanicals reported to affect warfarin sodium tablets therapy include the following: Bromelains, danshen, dong quai (Angelica sinensis), garlic, Ginkgo biloba, ginseng, and cranberry products are associated most often with an INCREASE in the effects of warfarin sodium tablets. Coenzyme Q10 (ubidecarenone) and St John’s wort are associated most often with a DECREASE in the effects of warfarin sodium tablets. Some botanicals may cause bleeding events when taken alone (e.g., garlic and Ginkgo biloba) and may have anticoagulant, antiplatelet and/or fibrinolytic properties. These effects would be expected to be additive to the anticoagulant effects of warfarin sodium tablets. Conversely, other botanicals may have coagulant properties when taken alone or may decrease the effects of warfarin sodium tablets Some botanicals that may affect coagulation are listed below for reference; however, this list should not be considered all-inclusive. Many botanicals have several common names and scientific names. The most widely recognized common botanical names are listed Botanicals that contain coumarins with potential anticoagulant effects:
- Contains coumarins, has antiplatelet properties, and may have coagulant properties due to possible Vitamin K content. † Contains coumarins and has antiplatelet properties. ‡ Contains coumarins and salicylates. § Contains coumarins and has fibrinolytic properties. ¶ Has antiplatelet and fibrinolytic properties (Dong Quai) (German and Roman) (Northern) weet Clover Bogbean‡ Horseradish Sweet Woodruff Boldo Licorice† Tonka Beans Buchu Meadowsweet‡ Wild Carrot Cassia† Miscellaneous botanicals with anticoagulant properties: Bladder Wrack (Fucus) Pau d’arco - Botanicals that contain salicylate and/or have antiplatelet properties: Agrimony Dandelion† Meadowsweet‡ Aloe Gel Feverfew Onion¶ Aspen Garlic¶ Policosanol Black Cohosh German Sarsaparilla Poplar Black Haw Ginger Senega Bogbean‡ Ginkgo Biloba Tamarind Cassia† Ginseng (Panax)¶ Willow Clove Licorice† Wintergreen Botanicals with fibrinolytic properties: Bromelains Garlic¶ Inositol Nicotinate Capsicum§ Ginseng Onion¶ (Panax)¶ Botanicals with coagulant properties: Agrimony Mistletoe Goldenseal Yarrow
The FDA drug label does not answer the question about coumarin cleanses.
From the Research
Coumarin Cleanses
- Coumarin is an anticoagulant found in warfarin, and its reversal is crucial in cases of over-anticoagulation or when urgent surgery is required 7, 8, 9, 10, 11
- Strategies to manage over-warfarinisation include withholding warfarin, administering vitamin K1, and using prothrombin complex concentrates (PCC) or fresh frozen plasma (FFP) 7, 10, 11
- PCC is preferred over FFP for immediate reversal due to its rapid and specific method of replacing vitamin K-dependent clotting factors and restoring normal hemostasis 10, 11
- The use of PCC is associated with a significant reduction in all-cause mortality, more rapid INR reduction, and less volume overload without an increased risk of thromboembolic events compared to FFP 11
- Vitamin K1 is essential for sustaining the reversal achieved by PCC or FFP, and its administration is crucial in the management of warfarin reversal 7, 9, 10
Reversal Strategies
- Withholding warfarin with careful subsequent monitoring is a safe strategy for patients with elevated INR (4.5-10.0) and no bleeding or high risk of bleeding 7
- Vitamin K1 can be given orally or intravenously to reverse the anticoagulant effect of warfarin, with the injectable formulation preferred for oral or intravenous administration 7
- PCC is preferred over FFP for urgent warfarin reversal due to its rapid and specific method of replacing vitamin K-dependent clotting factors and restoring normal hemostasis 10, 11
- Recombinant Factor VIIa (rFVIIa) has been used for emergent reversal of warfarin anticoagulation, but its use is less common compared to PCC 8
Clinical Outcomes
- The use of PCC is associated with a significant reduction in all-cause mortality compared to FFP (OR= 0.56, 95 % CI; 0.37-0.84, p=0.006) 11
- PCC use is more likely to achieve normalisation of international normalised ratio (INR) (OR 10.80, 95 % CI; 6.12-19.07) and results in a shorter time to INR correction (mean difference -6.50 hours, 95 %CI; -9.75 to -3.24) 11
- Patients receiving PCC have a lower risk of post-transfusion volume overload compared to FFP (OR 0.27, 95 % CI; 0.13-0.58) 11